2. MONETA G L. Sclerotherapy:Treatment of varicose and telangiectatic legveins[J]. Journal of Vascular Surgery, 1993, 15(5):941.
[2]
3. JIA X, MOWATT G, BURR J M, et al. Systematic review of foam sclerotherapy for varicose veins[J]. British Journal of Surgery, 2007, 94(8):925-936.
[3]
4. WEITZ-TUORETMAA A, RAUTIO R, VALKILA J, et al. Efficacy of OK-432 sclerotherapy in treatment of lymphatic malformations:long-term follow-up results[J]. Eur Arch Otorhinolaryngol, 2014, 271(2):385-390.
7. RIAL R, HERVAS L S, MONUX G, et al. Polidocanol foam stability in terms of its association with glycerin[J]. Phlebology, 2014, 29(5):304-309.
[6]
8. CEULEN R P, JAGTMAN E A, SOMMER A, et al. Blocking the saphenofemoral junction during ultrasound-guided foam sclerotherapy——assessment of a presumed safety-measure procedure[J]. Eur J Vasc Endovasc Surg, 2010, 40(6):772-776.
[7]
9. CABRERA J, CABRERA J R. Nuevo métodode esclerosis en las varices tronculares[J]. Patologia Vascular, 1995, 4:55-73.
[8]
10. HESSE G, BREU F X, KUSCHMANN A, et al. Sclerotherapy using air-or CO2-O2-foam. Post-approval study[J]. Phlebologie, 2012, 41(2):77-88.
[9]
11. HAMEL-DESNOS C, DESNOS P, WOLLMANN J C, et al. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein:initial results[J]. Dermatol Surg, 2003, 29(12):1170-1175; discussion 1175.
[10]
12. GLOVICZKI P, COMEROTA A J, DALSING M C, et al. The care of patients with varicose veins and associated chronic venous diseases:clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum[J]. J Vasc Surg, 2011, 53(5 Suppl):2S-48S.
[11]
13. TESSARI L, CAVEZZI A, FRULLINI A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins[J]. Dermatol Surg, 2001, 27(1):58-60.
15. STVCKER M, KOBUS S, ALTMEYER P, et al. Review of published information on foam sclerotherapy[J]. Dermatol Surg, 2010, 36(Suppl 2):983-992.
[14]
16. MURRAY B S. Stabilization of bubbles and foams[J]. Curr Opin Colloid Interface Sci, 2007, 12(4/5):232-241.
[15]
17. TESSARI L. Nouvelle technique d'obtention de la scleromousse[J]. Phlebologie, 2000, 53:129.
[16]
18. WOLLMANN J C. Sclerosant foams:Stabilities, physical properties and rheological behavior[J]. Phlebologie, 2010, 39(4):208-217.
[17]
20. PRUD R K, KHAN S A. Foams:Theory, measurements and applications[M]. New York:Dekker, 1996.
[18]
21. MINSSIEUX L, NABZAR L, CHAUVETEAU G, et al. Permeability damage due to asphaltene deposition:experimental and modeling aspects[J]. Oil & Gas Science and Technology, 1998, 53(3):313-327.
[19]
1. COMMITTEE G, FORCE T. Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins[J]. Journal of the American Academy of Dermatology, 1996, 34(3):523-528.
[20]
6. CAMERON E, CHEN T, CONNOR D E, et al. Sclerosant foam structure and stability is strongly influenced by liquid air fraction[J]. European Journal of Vascular and Endovascular Surgery, 2013, 46(4):488-494.
[21]
19. COHEN-ADDAD S, H？HLER R, PITOIS O. Flow in foams and flowing foams[J]. Annu Rev Fluid Mech, 2013, 45:241-267.
